Skip to content
Logo text: ISPOR Improving healthcare decisions

Health Technology Assessment Central

The HTA Resource Center for Informing Healthcare Decisions

  • Home
  • What Is HTA?
  • HTA News and Events
  • Resource Library
  • Governance
  • Policy Interchange
  • Training and Development
« Back to ISPOR.org

News

Q&A: European Commission Proposal on Health Technology Assessment

January 31, 2018

http://europa.eu/rapid/press-release_MEMO-18-487_en.htm

Posted in: Uncategorized

Post navigation

← EU Commission to Launch Health Technology Assessment Cooperation
Is Europe Ready for a Single Health Technology Assessment? →

News

The new definition of HTA: A milestone in international collaboration
Impact of a Global Pandemic on Health Technology Assessment
NEW HTAi – ISPOR Joint Deliberative Processes for HTA Task Force
Strategic collaboration announced by NICE and Health Technology Wales
NICE and LSE announce new Executive MSc in Evaluation of Health Care Interventions and Outcomes degree program, starting in April 2020
Why HTA and Pooled Purchasing Must Be at the Heart of Global Health Transitions
Health Technology Assessment Around the World: Broadening the Understanding of Cross-Country Differences
Ghana’s HTA agenda and UHC, what difference could HTA make?
AMCP releases the AMCP Format for Formulary Submissions, version 4.1
The ‘Top 10’ Challenges for Health Technology Assessment: INAHTA Viewpoint

Twitter

Tweets about #HTA

#HTA

ijtahcIJTAHC@ijtahc·
6h

The broader societal impacts of COVID-19 and the growing importance of capturing these in health economic analyses. https://www.cambridge.org/core/journals/international-journal-of-technology-assessment-in-health-care/article/broader-societal-impacts-of-covid19-and-the-growing-importance-of-capturing-these-in-health-economic-analyses/E559D6B335BD9A64F80F6511BE1330F7 #IJTAHC #HTA #EconomicEvaluation #TopPapers2021

Reply on Twitter 1467493964454535176Retweet on Twitter 1467493964454535176Like on Twitter 1467493964454535176Twitter 1467493964454535176
RuaraidhHillRuaraidh Hill@RuaraidhHill·
9h

HTA and Pharmacy - DAY 2 - Evidence for HTA; HTA for practice sessions continue.... w/ great insight into NICE 'reference case' modelling w/ @livUniLRiG colleague James Mahon - Medical University of Sofia - #referencecase #HTA #Sofia 🇧🇬 https://mu-sofia.bg/en/

Reply on Twitter 1467448919730884610Retweet on Twitter 14674489197308846101Like on Twitter 1467448919730884610Twitter 1467448919730884610
HenryJOncologyDr Henry@HenryJOncology·
22h

Its simple: time spent by patients, regardless of their productivity, is a cost (duh). They know it, their families know it, but #HTA and payers dont incorporate it.

So, use time-driven activity based costing to add up the time spent by patients+ and account for it!

Reply on Twitter 1467252512914919433Retweet on Twitter 1467252512914919433Like on Twitter 1467252512914919433Twitter 1467252512914919433
Load More...
Privacy Policy | Disclaimer
Copyright © 2021 ISPOR – The Professional Society for Health Economics and Outcomes Research